80370-42-9 | Ethyl-2-formyl-3-oxopropionate

Packsize	Purity	Availability	Price	Discounted Price
250mg	95%	in stock	$15.00	$10.00
1g	95%	in stock	$16.00	$11.00
5g	95%	in stock	$34.00	$24.00
25g	95%	in stock	$79.00	$56.00
100g	95%	in stock	$262.00	$184.00
500g	95%	in stock	$873.00	$611.00

Description

• Catalog Number: AB46929
• Chemical Name: Ethyl-2-formyl-3-oxopropionate
• CAS Number: 80370-42-9
• Molecular Formula: C6H8O4
• Molecular Weight: 144.1253
• MDL Number: MFCD11112084
• SMILES: CCOC(=O)C(C=O)C=O

Computed Properties

• Complexity: 133
• Covalently-Bonded Unit Count: 1
• Heavy Atom Count: 10
• Hydrogen Bond Acceptor Count: 4
• Rotatable Bond Count: 5
• XLogP3: -0.2

Upstream Synthesis Route

Ethyl 2-formyl-3-oxopropanoate, also known as acetylacetone ethylhemiacetal, is a versatile compound widely used in chemical synthesis processes. This compound serves as a key building block in the production of various pharmaceuticals, agrochemicals, and fine chemicals.In chemical synthesis, Ethyl 2-formyl-3-oxopropanoate is commonly employed as a precursor in the synthesis of complex organic molecules. Its functional groups allow for multiple reactions, making it valuable in the formation of diverse chemical structures. One of its primary applications is as a starting material for the synthesis of pyrazole derivatives, which are essential in the pharmaceutical industry for their biological activities.Furthermore, Ethyl 2-formyl-3-oxopropanoate is utilized to create chiral ligands that are crucial in asymmetric catalysis, a key technique in producing enantiomerically pure compounds. Its reactivity and compatibility with various functional groups make it a favored choice in organic synthesis for introducing new functionalities and creating structurally complex molecules.Overall, Ethyl 2-formyl-3-oxopropanoate plays a significant role in modern chemical synthesis, enabling chemists to access a wide range of compounds with diverse applications in different industries.

Literature

• Regadenoson in the detection of coronary artery disease.

  Vascular health and risk management 20080401